Want to see JP:5142 full AI Analyst Report?
Top Page
Achilles Corporation
(5142)
Select Model
Select Model
Rating:63Neutral
Price Target:
¥1,799.00
▲(24.41% Upside)
Action:Reiterated
Date:08/09/26
The score is led by attractive valuation (low P/E and ~3.1% yield) and strong technical momentum (price above all major moving averages). These positives are offset by weaker financial quality, primarily persistent negative free cash flow and a volatile earnings track record despite the 2026 profitability recovery.
Positive Factors
Profitability Recovery
A clear return to profitability in 2026 signals that operational adjustments and demand recovery produced sustainable positive earnings over the most recent period. This improves the firm's ability to reinvest, service liabilities, and execute medium-term plans versus prior loss years.
Negative Factors
Persistent negative free cash flow
Consistent negative free cash flow, even in a profitable year, shows the company struggles to convert accounting profits into surplus cash after investments. This structural cash burn constrains self-funding ability for capex, dividends, or debt reduction and raises reliance on external financing.
Read all positive and negative factors
Positive Factors
Negative Factors
Profitability Recovery
A clear return to profitability in 2026 signals that operational adjustments and demand recovery produced sustainable positive earnings over the most recent period. This improves the firm's ability to reinvest, service liabilities, and execute medium-term plans versus prior loss years.
Read all positive factors
Achilles Corporation (5142) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥18.70B
Dividend Yield3.08%
Average Volume (3M)60.26K
Price to Earnings (P/E)8.4
Beta (1Y)1.12
Revenue Growth3.43%
EPS Growth490.61%
CountryJP
Employees1,596
SectorGeneral
Sector StrengthN/A
IndustryChemicals
Share Statistics
EPS (TTM)154.83
Shares Outstanding14,562,714
10 Day Avg. Volume46,570
30 Day Avg. Volume60,263
Financial Highlights & Ratios
PEG Ratio0.02
Price to Book (P/B)0.42
Price to Sales (P/S)0.22
P/FCF Ratio-75.51
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Achilles Corporation Business Overview & Revenue Model
Company Description
Achilles Corporation, a Tokyo-based company founded in 1947 and formerly known as Kohkoku Chemical Industry until its 1982 rebranding, is a diverse manufacturer and supplier of footwear, plastic goods, and industrial materials. While maintaining a...
How the Company Makes Money
Achilles Corporation makes money primarily by manufacturing and selling rubber/plastics-based products and materials to business customers and end markets, generating revenue from product sales (shipment-based) across its operating segments. Key r...
Achilles Corporation Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
66
Positive
Cash Flow
34
Negative
| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 81.80B | 79.09B | 78.61B | 82.92B | 75.95B |
| Gross Profit | 17.52B | 14.19B | 14.18B | 14.85B | 15.66B |
| EBITDA | 5.71B | 3.81B | -1.21B | 2.13B | 5.42B |
| Net Income | 2.12B | 427.00M | -8.21B | -1.20B | 1.52B |
Balance Sheet | |||||
| Total Assets | 83.63B | 79.50B | 82.66B | 86.22B | 80.12B |
| Cash, Cash Equivalents and Short-Term Investments | 9.75B | 7.72B | 6.85B | 6.89B | 7.59B |
| Total Debt | 17.15B | 14.65B | 14.65B | 11.10B | 5.20B |
| Total Liabilities | 40.34B | 40.17B | 43.11B | 40.01B | 32.39B |
| Stockholders Equity | 43.28B | 39.34B | 39.55B | 46.21B | 47.73B |
Cash Flow | |||||
| Free Cash Flow | -238.00M | -1.11B | -2.37B | -5.91B | -1.41B |
| Operating Cash Flow | 2.64B | 2.69B | 1.88B | -1.07B | 4.71B |
| Investing Cash Flow | -2.86B | -1.92B | -3.79B | -4.48B | -5.03B |
| Financing Cash Flow | 2.15B | -1.25B | 1.76B | 4.55B | -860.00M |
Achilles Corporation Technical Analysis
Positive
1446.00
Price Trends
1222.30
Positive
1301.69
Positive
1350.06
Positive
Market Momentum
64.72
Negative
86.00
Negative
93.90
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:5142, the sentiment is Positive. The current price of 1446 is above the 20-day moving average (MA) of 1293.05, above the 50-day MA of 1222.30, and above the 200-day MA of 1350.06, indicating a bullish trend. The MACD of 64.72 indicates Negative momentum. The RSI at 86.00 is Negative, neither overbought nor oversold. The STOCH value of 93.90 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:5142.
Achilles Corporation Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥39.10B | 7.95 | ― | 3.53% | -7.83% | 13.39% | |
74 Outperform | ¥102.78B | 38.18 | ― | 0.67% | 8.51% | -17.90% | |
65 Neutral | ¥7.31B | 17.36 | ― | 2.97% | -0.78% | -41.25% | |
63 Neutral | ¥18.70B | 8.38 | ― | 1.39% | 3.43% | 490.61% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
55 Neutral | ¥22.00B | 29.36 | ― | 4.09% | 0.96% | -6.54% |
* General Sector Average
JP:5142
Achilles Corporation
1,689.00
564.22
50.16%
JP:3553
Kyowa Leather Cloth Co., Ltd.
915.00
141.68
18.32%
JP:4531
Yuki Gosei Kogyo Co., Ltd.
350.00
86.67
32.91%
JP:4970
Toyo Gosei Co., Ltd.
13,540.00
8,515.60
169.48%
JP:5013
Yushiro Chemical Industry Co., Ltd.
3,185.00
1,068.53
50.49%
Achilles Corporation Corporate Events
Achilles to Book ¥1.3 Billion Extraordinary Gain From Cross-Shareholding Sale
Aug 7, 2026
Achilles Corporation has resolved to sell a portion of its cross-shareholdings, consisting of five listed stocks, as part of its ongoing effort to reduce such holdings and improve capital efficiency. The planned divestment, scheduled between Augus...
Achilles Sets Targeted Cut in Cross-Shareholdings to Boost Capital Efficiency
Aug 7, 2026
Achilles Corporation has approved a new policy to significantly reduce its cross-shareholdings, aiming to cut the ratio of these holdings to less than 20% of consolidated net assets by fiscal year 2027. The move reflects growing emphasis on capita...
Achilles Releases Q1 FY2026 Results Outline and FY2027 Forecast Framework
Aug 7, 2026
Achilles Corporation has released supplementary materials covering its financial performance for the three months ended June 30, 2026, along with forecasts for the fiscal year ending March 31, 2027. The disclosure signals ongoing transparency arou...
Achilles Lifts Profit Outlook and Boosts Dividend on Securities Sale
Aug 7, 2026
Achilles Corporation has revised its profit forecast for the fiscal year ending March 31, 2027, keeping sales and operating metrics unchanged while sharply raising projected profit attributable to owners of the parent. The upgrade stems from a pla...
Achilles Posts Strong Q1 Earnings but Flags Profit Slowdown, Lifts Dividend Outlook
Aug 7, 2026
Achilles Corporation reported strong results for the quarter ended June 30, 2026, with net sales rising 16.2% year on year to ¥21.36 billion and operating profit surging 164.0%. Ordinary profit climbed 306.4% and profit attributable to owners...
Achilles lifts profits on restructuring and high-value materials growth
Jun 15, 2026
Achilles Corporation reported that a comprehensive restructuring of its business organizations, combined with structural reforms in its shoes segment, has sharpened its focus on selected businesses and significantly boosted its operating profit ma...
Achilles Unveils FY2026 Results, FY2027 Outlook and Mid-Term Plan Progress
May 12, 2026
Achilles Corporation released supplementary materials outlining its financial results for the fiscal year ended March 31, 2026, and provided forecasts for the year ending March 31, 2027, alongside an update on the progress of its mid-term manageme...
Achilles lifts profit forecasts beat and doubles year-end dividend on stronger margins
May 12, 2026
Achilles Corporation reported full-year results for the period ended March 31, 2026, that surpassed its earlier forecasts on both a consolidated and non-consolidated basis, driven by a richer sales mix of high-margin medical and industrial films a...
Achilles rebounds to strong profit, doubles dividend but guides for weaker year ahead
May 12, 2026
Achilles Corporation reported a 3.4% increase in net sales to ¥81.8 billion for the fiscal year ended March 31, 2026, with operating profit rebounding to ¥2.97 billion from a loss and profit attributable to owners of the parent surging t...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.